- Display 15 Products per page
Precision Cancer Therapeutics Market, 2022
Published: October 25, 2022 | Price: $5,000.00 – $10,000.00
Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry. Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...
Reimbursement for IVD Tests
Published: October 25, 2013 | Price: $1,995.00 – $3,900.00
What is the procedure, for establishing reimbursement for an IVD test product? What companies have been successful and how? What changes will IVD makers face in the near-term. This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions and provides authoritative data for IVD business planners. One of the critical factors for the success of an IVD product is reimbursement. Reimbursement is a critical component of the health care landscape and will continue to have a major...
In Vitro Diagnostics Business Outlook, 2024 (6 updates)
Published: December 20, 2024 | Price: $4,995.00 – $9,995.00
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually. In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including: Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities A comprehensive view of the IVD market with test categories covered and company briefs M&A activities, selected partnerships & collaborations, partnership deals, and more Industry & region watch to help tailor strategies Analysis of news and events and reporting on...
IVD in India
Published: January 6, 2016 | Price: $3,360.00 – $6,720.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2020, and IVD revenues in India by market sector (immunoassays, clinical chemistry,...
Inhaled Insulin: A Market Briefing
Published: July 1, 2004 | Price: $895.00 – $1,790.00
Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear. This...
Worldwide Facial Rejuvenation Markets, 4th Edition ( Topical Rejuvenation Products, Fillers and Botulism Products, Laser Resurface, Tumescent Liposuction Products, Chemical Peel, Dermabrasion, Microdermabrasion, Surgical Restoration )
Published: January 17, 2013 | Price: $2,500.00 – $5,000.00
Facial rejuvenation covers a wide range of product and service markets involving the treatment of the effects of aging on the human face. Products such as Botox® and derma fillers, equipment such as lasers and photodynamic therapy systems and services such as chemical peels and microbrasions are covered. and The aging of the population, namely the baby boomer demographic segment is driving the market. The size and wealth of this aging segment and its overwhelming desire to retain a youthful...
Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends)
Published: February 23, 2013 | Price: $3,995.00 – $7,990.00
This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens. The report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories. Many clinical laboratories are facing a number of issues that are challenging their ability to remain competitive. These challenges...
Drug Pricing and Reimbursement Strategies: Preparing for the Coming Generic Onslaught
Published: October 1, 2007 | Price: $995.00 – $1,990.00
It can be said that pharmaceutical companies face a 'new era.' in the coming years. Old strategies will not produce the same results. A wave of generic competition is poised to affect most brands. Drug companies have had to cut research budgets, leading to a dearth of new products on the market. This means there is very little margin for error in the pricing decision. Drug pricing is one of the key levers that determine the profitability of a drug...
The Worldwide Market for Cancer Diagnostics, 4th Edition
Published: April 1, 2010 | Price: $4,200.00 – $8,400.00
Since Kalorama Information last updated our comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of service products , PGx testing and tissue microarrays are showing an increased presence. Some companies who promised much in the past have not produced results. And new entrants have entered the field. These changes and more are addressed in Kalorama Information's Worldwide Market for Cancer Diagnostics, 4th. Edition. This report authored...
US Healthcare Data
Published: February 10, 2017 | Price: $200.00 – $400.00
US Healthcare Data United states statisitcs on healthcare expenditure (by payor and by category), medical conditions, office visits and counts of hospitals and other facilities are provided in this report. Important trends are noted.
Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes)
Published: May 4, 2018 | Price: $4,500.00 – $9,000.00
Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) analyzes the current and potential world market for single use systems for upstream bioprocessing. This report generally reviews the nature and direction of research, as well as future markets. Market forecasts cover various segments from 2016-2021, including global revenues for single use upstream processing;...
In Vitro Diagnostics (IVD) Market in China, 2021
Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...
Molecular Cancer Diagnostics Market
Published: February 12, 2020 | Price: $5,500.00 – $11,000.00
The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular diagnostics. PCR is the initial step used in isolating and amplifying specific regions of...
Expected High Growth Market Segments in Molecular Diagnostic Testing
Published: December 14, 2017 | Price: $2,000.00 – $4,000.00
Expected High Growth Market Segments in Molecular Diagnostic Testing Tests for hepatitis, nucleic acid blood testing and respiratory testing are among the fast-growing segments of molecular testing in 2018, according to a new report from Kalorama Information. will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report. Average molecular IVD products will see six percent growth, the areas identified will be higher, over the next five years. These are among the findings in...
Medical Imaging Markets, Volume IV – Contrast Agents
Published: February 1, 2007 | Price: $1,995.00 – $5,990.00
Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...